Search results for "MSI"

showing 10 items of 75 documents

Clumsiness in Adolescence: Educational, Motor, and Social Outcomes of Motor Delay Detected at 5 Years

1994

This paper reports the follow-up at age 15 of a group of children who were diagnosed at age 5 as having delayed motor development. The group of children who were clumsy and the control group still differed in motor performance 10 years later: 46% of the members of the early motor delay group were classified as different from the control group on motor and perceptual tasks. The remainder made up an intermediate group that could not be clearly distinguished from the other groups. Adolescents with stable motor problems had fewer social hobbies and pastimes and had lower academic ambitions for their future than the controls, although the lower academic ambitions also reflect their lower academi…

School performanceMotor delayClumsinessPerceptionmedia_common.quotation_subjectErikson's stages of psychosocial developmentPhysical Therapy Sports Therapy and RehabilitationAcademic achievementSocial acceptancePsychologyMotor skillDevelopmental psychologymedia_commonAdapted Physical Activity Quarterly
researchProduct

Can the tumor-agnostic evaluation of MSI/MMR status be the common denominator for the immunotherapy treatment of patients with several solid tumors?

2022

Alterations in short-repetitive DNA sequences, known as microsatellite instability (MSI), can reflect deficiencies in Mismatch Repair (MMR) system which represents a major player in DNA integrity maintenance. The incidence of MSI-H/dMMR has been shown to be variable depending on the tumor type. Several studies confirmed that dMMR/MSI status, although less frequent than PD-L1 expression, may better predict response to immune-checkpoint inhibitors (ICIs) in patients with solid tumors. In October 2016, the FDA granted pembrolizumab as breakthrough therapy for the treatment of non-CRC, MSI-H/dMMR tumors, providing, for the first time, a tumor-agnostic indication. In the next future, the tissue-…

Settore MED/06 - Oncologia MedicaHematologyMMR deficiencyColorectal cancerMMRPD-1/PD-L1DNA Mismatch RepairTumor-agnostic therapyOncologyNeoplasmsSolid tumorsHumansMicrosatellite InstabilityImmunotherapyColorectal NeoplasmsMSI
researchProduct

Analisi della distribuzione delle Monilofite omosporee nelle isole circumsiciliane

2009

Sicilia isole circumsiciliane felci monilofite flora biogeografia
researchProduct

Characterization of field isolates of Trichoderma antagonistic against Rhizoctonia solani.

2010

The aim of the present study was to characterize sixteen isolates of Trichoderma originating from a field of sugar beet where disease patches caused by Rhizoctonia solani were observed. Use of both molecular and morphological characteristics gave consistent identification of the isolates. Production of water-soluble and volatile inhibitors, mycoparasitism and induced systemic resistance in plant host were investigated using in vitro and in vivo tests in both sterilized and natural soils. This functional approach revealed the intra-specific diversity as well as biocontrol potential of the different isolates. Different antagonistic mechanisms were evident for different strains. The most antag…

VOLATILE INHIBITORSHypha[SDV]Life Sciences [q-bio]PopulationMolecular Sequence DataTRICHODERMA RICHODERMA GAMSIIPlant disease resistanceMicrobiologyRhizoctoniaRhizoctonia solaniAntibiosisGeneticsFUNGAL INTERACTIONSeducationPest Control BiologicalPathogenEcology Evolution Behavior and SystematicsSoil MicrobiologyPlant DiseasesCOILINGTrichodermaeducation.field_of_studybiologyAntibiosisTRICHODERMAVELUTINUMfood and beveragesbiology.organism_classificationBIOCONTROLInfectious DiseasesWATER-SOLUBLE INHIBITORSTrichoderma[SDE]Environmental SciencesSugar beetBeta vulgarisFungal biology
researchProduct

Williams-aikuisten kognitiivinen profiili ja yksilöiden väliset erot

2001

Williamsin syndroomakognitiivinen profiilifenotyyppikognitiivinen psykologiagenotyyppi
researchProduct

Use of hospital and amubutory data in assessment of screnning, follow-up and complications of diabetes mellitus

2017

Diabetes is a priority health target worldwide. Access to conclusive data is equally a priority in order to establish clear objectives and to implement coordinated action. Medico-administrative databases are being used more and more frequently for this purpose. We set out to illustrate and assess the interest of using a French healthcare consumption database to evaluate screening, surveillance and the risk of acute or chronic complications of diabetes in certain at-risk populations. We concluded that early screening for type-2 diabetes in women with a history of gestational diabetes was inadequate. Although a slight improvement occurred following the recommendations published in 2010, one w…

[SDV.MHEP] Life Sciences [q-bio]/Human health and pathologyPmsiDiabète gestationnelGestational diabetes mellitusDonnées médico-AdministrativesDiabète type 2Cardio-Vascular diseasesMaladies cardio-VasculairesType 2 diabetes mellitusHospital dataSchizophreniaSchizophrénie[SDV.MHEP]Life Sciences [q-bio]/Human health and pathologyAmbulatory data
researchProduct

Osteonecrosis of jaw beyond antiresorptive (bone-targeted) agents: new horizons in oncology

2016

Introduction: Osteonecrosis of the jaw (ONJ) is a clinically important, potentially painful and debilitating condition, which can affect the quality of life of cancer patients. Since 2003, ONJ appeared as a Bisphosphonate(BP)-related class effect, and the term Bisphosphonate-Related Osteonecrosis of the Jaw (BRONJ) was widespread. Areas Covered: Under discussion in this review is the fact that ONJ cases have been reported after treatment including antiangiogenic agents and other “targeted therapy”, with and without BPs. Consequently, the comprehensive term Medication-Related Osteonecrosis of the Jaw (MRONJ) has been introduced. The clinical aspects and the prognosis of ONJ associated with t…

aflibercept; bevacizumab; Bisphosphonate; Bisphosphonate-Related Osteonecrosis of the Jaw (BRONJ); denosumab; everolimus; Medication-Related Osteonecrosis of the Jaw (MRONJ); Osteonecrosis of the jaw (ONJ); sunitinib; temsirolimus; Angiogenesis Inhibitors; Antineoplastic Agents; Bisphosphonate-Associated Osteonecrosis of the Jaw; Humans; Jaw Diseases; Molecular Targeted Therapy; Neoplasms; Osteonecrosis; Quality of Life; Risk Assessment; Pharmacology (medical)Oncologysunitinibmedicine.medical_treatmentAngiogenesis InhibitorstemsirolimuTargeted therapyAntineoplastic Agent0302 clinical medicineNeoplasmsPharmacology (medical)Molecular Targeted TherapyJaw DiseaseafliberceptOsteonecrosisGeneral MedicineDenosumab030220 oncology & carcinogenesisOsteonecrosiBisphosphonate-Associated Osteonecrosis of the JawAngiogenesis InhibitorHumanmedicine.drugmedicine.medical_specialtyBevacizumabAntineoplastic AgentsbevacizumabRisk AssessmentBisphosphonate-Related Osteonecrosis of the Jaw (BRONJ)Medication-Related Osteonecrosis of the Jaw (MRONJ)03 medical and health sciencesInternal medicinemedicineBisphosphonateHumansBisphosphonate-associated osteonecrosis of the jawbusiness.industryeverolimuCancerdenosumab030206 dentistryBisphosphonatemedicine.diseaseOsteonecrosis of the jaw (ONJ)Quality of LifeNeoplasmJaw DiseasesOsteonecrosis of the jawbusinessJaw DiseasesExpert Opinion on Drug Safety
researchProduct

Musashi-2 contributes to myotonic dystrophy muscle dysfunction by promoting excessive autophagy through miR-7 biogenesis repression

2021

Skeletal muscle symptoms strongly contribute to mortality of myotonic dystrophy type 1 (DM1) patients. DM1 is a neuromuscular genetic disease caused by CTG repeat expansions that, upon transcription, sequester the Muscleblind-like family of proteins and dysregulate alternative splicing of hundreds of genes. However, mis-splicing does not satisfactorily explain muscle atrophy and wasting, and several other contributing factors have been suggested, including hyperactivated autophagy leading to excessive catabolism. MicroRNA ( miR ) -7 has been demonstrated to be necessary and sufficient to repress the autophagy pathway in cell models of the disease, but the origin of its low levels in DM1 was…

autophagyMSI2 antisense oligonucleotides autophagy miR-7 muscle atrophy muscle dysfunction myotonic dystrophy myotubesRM1-950BiologyMyotonic dystrophyMSI2chemistry.chemical_compoundDrug DiscoverymedicineMyocyteGene silencingMBNL1muscle dysfunctionmyotonic dystrophyMyogenesisAutophagymiR-7Skeletal musclemedicine.diseaseMuscle atrophyCell biologymedicine.anatomical_structurechemistryMolecular MedicineTherapeutics. Pharmacologyantisense oligonucleotidesmedicine.symptomMolecular Therapy - Nucleic Acids
researchProduct

Experimental observation of Electronic Metal support interaction: investigation of Au/Ceria catalysts by HERFD–XANES

2015

In this paper we report the result of a recent experiment of high resolution XANES (HERFD-XANES) which evidenced this modification suggesting that gold clusters with very similar size can have a modified electronic structure (the empty d-Density-of-states) when they are deposited on ceria and titania oxide

ceria SMSI gold catalyst XANES HERFD
researchProduct

Chirurgie combinée de la cataracte et endophtalmie postopératoire aiguë en France de 2005 à 2014

2018

Introduction : L’objectif de cette étude était d’analyser l’association entre chirurgie de la cataracte combinée avec des interventions chirurgicales de traitement du glaucome, vitréorétiniennes ou cornéennes et la survenue d’une (EPOA), de 2005 à 2014 en France. Méthodes : Les procédures de chirurgie de la cataracte par phacoémulsification et/ou de traitement du glaucome, vitréorétiniennes ou cornéennes ont été repérées par les codes correspondant de la classification commune des actes médicaux (CCAM) dans le programme de médicalisation des systèmes d’information (PMSI) du 1er janvier 2005 au 31 décembre 2014. L’EPOA était définie par la présence d’un diagnostic d’endophtalmie lors d’une h…

chirurgie combinée de la cataracteendophtalmie postopératoire aiguëEpidemiology[SDV]Life Sciences [q-bio][SDV.IDA]Life Sciences [q-bio]/Food engineeringPublic Health Environmental and Occupational Health[SPI.GPROC]Engineering Sciences [physics]/Chemical and Process EngineeringPMSIphacoémulsificationétude nationale
researchProduct